e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Lung infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community-acquired pneumonia (CAP) and mortality risk in patients with congestive heart failure (CHF)
A. K. Starodubcev, D. E. Arkhipova (Moscow, Russia)
Source:
Annual Congress 2002 - Lung infections
Session:
Lung infections
Session type:
Thematic Poster Session
Number:
2814
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. K. Starodubcev, D. E. Arkhipova (Moscow, Russia). Community-acquired pneumonia (CAP) and mortality risk in patients with congestive heart failure (CHF). Eur Respir J 2002; 20: Suppl. 38, 2814
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Diagnosis on community-acquired pneumonia (CAP) in patients with congestive heart failure (CHF)
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
Community-acquired pneumonia as a cause of acute respiratory failure (ARF) in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 518s
Year: 2005
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
C-reactive protein (C-RP) in patients with chronic heart failure (CHF) and community-acquired pneumonia (CAP): usefulness to guide antibiotic prescription
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Acute hemodynamic effects of non-invasive ventilation (NIV) in patients with exacerbation of congestive heart failure (CHF)
Source: Eur Respir J 2005; 26: Suppl. 49, 550s
Year: 2005
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Type of acute respiratory failure and development of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013
Noninvasive ventilation (NIV) in acute decompensated heart failure (ADHF) in patients with ischemic and idiopathic dilated cardiomyopathy
Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation
Year: 2007
Antibacterial therapy of community-acquired pneumonia (CAP) at patients with cardiovascular diseases (CVD)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012
Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009
Community-acquired pneumonia (CAP) in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes?
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009
COPD in heart failure patients
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prevalence and characteristics of congestive heart failure in elderly patients with chronic lung disease
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009
Efficacy of non invasive mechanical ventilation (NIV) for acute respiratory failure (ARF) in COPD patients with and without pneumonia
Source: Annual Congress 2012 - Noninvasive ventilation for weaning and acute exacerbation management of airway obstruction
Year: 2012
Community-acquired pneumonia: treatment failure and complications
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept